Transcode Therapeutics Stock Price History

RNAZ Stock  USD 9.69  0.25  2.52%   
If you're considering investing in Transcode Stock, it is important to understand the factors that can impact its price. As of today, the current price of Transcode Therapeutics stands at 9.69, as last reported on the 22nd of July, with the highest price reaching 9.90 and the lowest price hitting 9.38 during the day. Transcode Therapeutics appears to be moderately volatile, given 3 months investment horizon. Transcode Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0602, which indicates the firm had a 0.0602 % return per unit of risk over the last 3 months. By inspecting Transcode Therapeutics' technical indicators, you can evaluate if the expected return of 0.55% is justified by implied risk. Please review Transcode Therapeutics' Semi Deviation of 7.91, risk adjusted performance of 0.0305, and Coefficient Of Variation of 4330.14 to confirm if our risk estimates are consistent with your expectations.
At this time, Transcode Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 64.2 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (1.9 M). . Price Earnings Ratio is likely to drop to -1.47 in 2025. Price Book Value Ratio is likely to drop to -12.24 in 2025. Transcode Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0602

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsRNAZ
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 9.18
  actual daily
82
82% of assets are less volatile

Expected Return

 0.55
  actual daily
11
89% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average Transcode Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Transcode Therapeutics by adding it to a well-diversified portfolio.
Price Book
0.7849
Book Value
12.347
Enterprise Value
2.3 M
Enterprise Value Ebitda
(0.59)
Shares Float
780.1 K

Transcode Therapeutics Stock Price History Chart

There are several ways to analyze Transcode Stock price data. The simplest method is using a basic Transcode candlestick price chart, which shows Transcode Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMay 1, 202515.79
Lowest PriceMay 19, 20256.7

Transcode Therapeutics July 22, 2025 Stock Price Synopsis

Various analyses of Transcode Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Transcode Stock. It can be used to describe the percentage change in the price of Transcode Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Transcode Stock.
Transcode Therapeutics Price Daily Balance Of Power(0.48)
Transcode Therapeutics Price Action Indicator(0.08)
Transcode Therapeutics Accumulation Distribution 605.51 
Transcode Therapeutics Price Rate Of Daily Change 0.97 

Transcode Therapeutics July 22, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Transcode Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Transcode Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Transcode Stock and then apply it to test your longer-term investment strategies against Transcode.

Transcode Stock Price History Data

The price series of Transcode Therapeutics for the period between Wed, Apr 23, 2025 and Tue, Jul 22, 2025 has a statistical range of 9.09 with a coefficient of variation of 21.02. The price distribution for the period has arithmetic mean of 8.72. The median price for the last 90 days is 8.21. The company completed stock split (1:28) on 15th of May 2025.
OpenHighLowCloseVolume
07/21/2025
 9.64  9.90  9.38  9.69  11,528 
07/18/2025
 10.10  10.38  9.02  9.94  35,542 
07/17/2025
 9.45  10.30  9.13  10.05  33,920 
07/16/2025
 8.91  9.44  8.78  9.38  32,245 
07/15/2025
 8.82  8.92  8.65  8.72  11,495 
07/14/2025
 8.55  9.15  8.28  9.11  14,120 
07/11/2025
 8.91  8.91  8.50  8.69  19,888 
07/10/2025
 8.99  9.34  8.78  9.00  29,923 
07/09/2025
 9.07  9.52  9.00  9.13  27,750 
07/08/2025
 8.10  9.70  8.04  9.25  44,677 
07/07/2025
 8.49  8.61  8.05  8.05  12,968 
07/03/2025
 8.60  8.65  8.42  8.45  13,376 
07/02/2025
 7.75  8.35  7.74  8.29  23,133 
07/01/2025
 7.97  7.99  7.41  7.50  45,400 
06/30/2025
 7.78  8.00  7.50  7.80  12,081 
06/27/2025 8.21  8.40  7.81  7.97  14,750 
06/26/2025
 7.71  8.48  7.70  8.21  36,741 
06/25/2025
 7.95  7.95  7.52  7.66  7,921 
06/24/2025
 7.32  8.45  7.32  7.79  50,086 
06/23/2025
 7.51  7.70  7.36  7.50  10,909 
06/20/2025
 7.00  7.92  6.88  7.57  60,647 
06/18/2025
 6.94  7.08  6.80  6.98  15,350 
06/17/2025
 7.07  7.20  6.82  6.82  21,585 
06/16/2025
 6.75  7.35  6.75  7.30  30,757 
06/13/2025
 7.10  7.62  6.80  6.97  40,301 
06/12/2025
 7.55  7.91  7.18  7.21  37,496 
06/11/2025
 7.49  7.69  7.43  7.56  16,477 
06/10/2025
 7.52  7.62  7.27  7.37  14,256 
06/09/2025
 7.17  7.50  7.14  7.50  36,129 
06/06/2025
 7.12  7.46  7.02  7.14  33,529 
06/05/2025
 7.23  8.18  7.07  7.22  58,723 
06/04/2025
 7.21  7.49  7.02  7.39  43,565 
06/03/2025
 6.96  7.23  6.96  7.03  23,827 
06/02/2025
 6.80  7.36  6.80  7.09  64,252 
05/30/2025
 7.08  7.08  6.54  6.79  37,213 
05/29/2025
 7.00  7.20  6.85  6.90  50,170 
05/28/2025 6.87  7.46  6.85  6.97  57,914 
05/27/2025
 7.15  7.37  6.80  6.87  41,021 
05/23/2025
 7.44  7.62  6.87  6.97  64,242 
05/22/2025 7.99  8.06  7.30  7.62  69,380 
05/21/2025
 6.87  8.53  6.83  7.94  193,965 
05/20/2025
 6.45  7.23  6.45  7.01  159,950 
05/19/2025
 8.03  8.28  6.15  6.70  352,512 
05/16/2025
 7.53  8.32  7.43  8.16  111,425 
05/15/2025
 8.25  8.99  7.19  7.65  176,474 
05/14/2025 9.72  10.07  9.36  9.71  38,920 
05/13/2025
 9.52  9.95  9.01  9.72  44,422 
05/12/2025
 9.55  10.36  9.24  10.00  63,765 
05/09/2025
 10.08  10.08  8.96  9.57  36,883 
05/08/2025 9.95  9.98  7.68  9.81  106,477 
05/07/2025
 10.36  10.50  9.88  9.95  54,868 
05/06/2025
 11.45  11.48  9.86  10.14  80,253 
05/05/2025 11.70  12.60  11.48  11.83  109,662 
05/02/2025 15.68  15.99  13.44  14.34  301,825 
05/01/2025
 13.39  22.03  12.98  15.79  4,654,929 
04/30/2025
 11.90  11.90  10.82  11.38  64,699 
04/29/2025
 11.85  12.59  11.48  12.10  40,631 
04/28/2025
 10.64  12.32  10.64  11.81  114,326 
04/25/2025
 11.45  14.01  10.64  10.64  261,055 
04/24/2025
 8.86  13.11  8.86  11.20  366,227 
04/23/2025
 9.24  9.66  8.78  8.79  72,089 

About Transcode Therapeutics Stock history

Transcode Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Transcode is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Transcode Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Transcode Therapeutics stock prices may prove useful in developing a viable investing in Transcode Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding356.1 K373.9 K
Net Loss-15.8 M-15 M

Transcode Therapeutics Stock Technical Analysis

Transcode Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Transcode Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Transcode Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sectors Now

   

Sectors

List of equity sectors categorizing publicly traded companies based on their primary business activities
All  Next Launch Module

Transcode Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Transcode Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Transcode Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Transcode to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Transcode Stock Analysis

When running Transcode Therapeutics' price analysis, check to measure Transcode Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transcode Therapeutics is operating at the current time. Most of Transcode Therapeutics' value examination focuses on studying past and present price action to predict the probability of Transcode Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transcode Therapeutics' price. Additionally, you may evaluate how the addition of Transcode Therapeutics to your portfolios can decrease your overall portfolio volatility.